A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This trial is conducted in Europe. The aim of the trial is to investigate the pharmacokinetic (the exposure of the trial drug in the body) and pharmacodynamic (the effect of the investigated drug on the body) properties of FIAsp (faster-acting insulin aspart) in subjects with type 1 diabetes.
Epistemonikos ID: 383e981f46f5f6993f87318810e9be80d470c53c
First added on: May 11, 2024